• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于 COVID-19 感染的发病机制和免疫的当代综述。

A contemporary review on pathogenesis and immunity of COVID-19 infection.

机构信息

Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Mol Biol Rep. 2020 Jul;47(7):5365-5376. doi: 10.1007/s11033-020-05621-1. Epub 2020 Jun 29.

DOI:10.1007/s11033-020-05621-1
PMID:32601923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7323602/
Abstract

Emerging of the COVID-19 pandemic has raised interests in the field of biology and pathogenesis of coronaviruses; including interactions between host immune reactions specific, and viral factors. Deep knowledge about the interaction between coronaviruses and the host factors could be useful to provide a better support for the disease sufferers and be advantageous for managing and treatment of the lung infection caused by the virus. At this study, we reviewed the updated information on the pathogenesis of the COVID-19 and the immune responses toward it, with a special focus on structure, genetics, and viral accessory proteins, viral replication, viral receptors, the human immune reactions, cytopathic effects, and host-related factors.

摘要

新冠疫情的爆发引起了人们对冠状病毒生物学和发病机制的兴趣;包括宿主免疫反应特异性和病毒因素之间的相互作用。深入了解冠状病毒与宿主因素之间的相互作用,可以为患者提供更好的支持,有利于管理和治疗病毒引起的肺部感染。在本研究中,我们回顾了 COVID-19 的发病机制和免疫反应的最新信息,特别关注结构、遗传学和病毒辅助蛋白、病毒复制、病毒受体、人体免疫反应、细胞病变效应和宿主相关因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b3/7323602/66a0b5063022/11033_2020_5621_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b3/7323602/66a0b5063022/11033_2020_5621_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b3/7323602/66a0b5063022/11033_2020_5621_Fig1_HTML.jpg

相似文献

1
A contemporary review on pathogenesis and immunity of COVID-19 infection.关于 COVID-19 感染的发病机制和免疫的当代综述。
Mol Biol Rep. 2020 Jul;47(7):5365-5376. doi: 10.1007/s11033-020-05621-1. Epub 2020 Jun 29.
2
Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.解析 SARS-CoV-2 对 COVID-19 发病机制中宿主线粒体的劫持。
Am J Physiol Cell Physiol. 2020 Aug 1;319(2):C258-C267. doi: 10.1152/ajpcell.00224.2020. Epub 2020 Jun 8.
3
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.Ⅰ型和Ⅲ型干扰素限制 SARS-CoV-2 感染人呼吸道上皮细胞。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00985-20.
4
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.SARS-CoV-2 和 SARS-CoV 在人肺中的比较复制和免疫激活特征:一项具有 COVID-19 发病机制意义的离体研究。
Clin Infect Dis. 2020 Sep 12;71(6):1400-1409. doi: 10.1093/cid/ciaa410.
5
Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an hACE2 transfection mouse model.中性粒细胞趋化因子 CXCL5 在 hACE2 转染小鼠模型 SARS-CoV-2 感染诱导的肺部炎症性先天免疫反应中的作用。
Zool Res. 2020 Nov 18;41(6):621-631. doi: 10.24272/j.issn.2095-8137.2020.118.
6
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.SARS-CoV-2 感染期间免疫反应概述:从过去中吸取的教训。
Front Immunol. 2020 Aug 7;11:1949. doi: 10.3389/fimmu.2020.01949. eCollection 2020.
7
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?固有免疫信号和蛋白水解途径在新冠病毒 2 型(SARS-CoV-2)引起的新冠肺炎(Covid-19)中的转归或恶化:关键治疗靶点?
Front Immunol. 2020 May 28;11:1229. doi: 10.3389/fimmu.2020.01229. eCollection 2020.
8
Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.三种干扰素拮抗剂失活可减轻肠道冠状病毒的发病机制。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.00565-20.
9
Genomic Epidemiology and its importance in the study of the COVID-19 pandemic.基因组流行病学及其在新冠疫情研究中的重要性。
Infez Med. 2020;28(2):139-142.
10
Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.诱导抗病毒免疫反应及其被冠状病毒规避。
Viruses. 2020 Sep 18;12(9):1039. doi: 10.3390/v12091039.

引用本文的文献

1
Identification of Natural Compounds as Potential COVID-19 Main Protease (Mpro) Inhibitors: A Comprehensive Study and Evidence.鉴定天然化合物作为潜在的新型冠状病毒主要蛋白酶(Mpro)抑制剂:一项全面研究及证据
Curr Pharm Des. 2025;31(30):2416-2437. doi: 10.2174/0113816128344055250220100720.
2
A Multiple-Center, Retrospective Study of Characteristics and Outcomes of Hospitalized COVID-19 Patients with Cardiovascular Disease in North Iran.伊朗北部 COVID-19 合并心血管疾病住院患者特征和结局的多中心回顾性研究。
Ethiop J Health Sci. 2023 Jan;33(1):3-12. doi: 10.4314/ejhs.v33i1.2.
3
COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis.

本文引用的文献

1
Frontier Therapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review.严重急性呼吸综合征冠状病毒2(COVID-19)的前沿治疗方法与疫苗策略:综述
Iran J Public Health. 2020 Oct;49(Suppl 1):18-29. doi: 10.18502/ijph.v49iS1.3666.
2
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
3
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
全球孕妇对 COVID-19 疫苗的接受度:一项系统评价和荟萃分析。
PLoS One. 2022 Sep 28;17(9):e0272273. doi: 10.1371/journal.pone.0272273. eCollection 2022.
4
Evaluating immunohaematological profile among COVID-19 active infection and recovered patients in Ghana.评估加纳 COVID-19 活跃感染和康复患者的免疫血液学特征。
PLoS One. 2022 Sep 12;17(9):e0273969. doi: 10.1371/journal.pone.0273969. eCollection 2022.
5
Visual Detection of COVID-19 from Materials Aspect.从材料角度对新型冠状病毒肺炎的视觉检测
Adv Fiber Mater. 2022;4(6):1304-1333. doi: 10.1007/s42765-022-00179-y. Epub 2022 Aug 8.
6
A systems biology analysis of protein-protein interaction of digestive disorders and Covid-19 virus based on comprehensive gene information.基于全面基因信息的消化系统疾病与新冠病毒蛋白质-蛋白质相互作用的系统生物学分析
Gastroenterol Hepatol Bed Bench. 2022 Spring;15(2):158-163.
7
Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.2019 年冠状病毒病(COVID-19)更新:从代谢重编程到免疫代谢。
J Med Virol. 2022 Oct;94(10):4611-4627. doi: 10.1002/jmv.27929. Epub 2022 Jun 20.
8
Pandemic impact on patients with advanced non-COVID-19 illness and their family carers receiving specialised palliative home care: a qualitative study.大流行对接受专科姑息治疗的晚期非 COVID-19 疾病患者及其家庭照护者的影响:一项定性研究。
BMJ Open. 2022 May 19;12(5):e059577. doi: 10.1136/bmjopen-2021-059577.
9
Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19.血管紧张素肽失调:COVID-19 发病机制中的谜团。
Mediators Inflamm. 2022 Feb 8;2022:7423537. doi: 10.1155/2022/7423537. eCollection 2022.
10
Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection.了解 COVID-19 的基因表达和转录组谱:针对 SARS-CoV-2 感染的保护性免疫基因进行映射的计划。
Front Immunol. 2021 Dec 15;12:724936. doi: 10.3389/fimmu.2021.724936. eCollection 2021.
COVID-19 中的细胞因子风暴:趋化因子/趋化因子受体系统的参与概述。
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
4
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?综述:补体或接触系统在新型冠状病毒肺炎的保护或发病机制中起作用吗?
Pulm Ther. 2020 Dec;6(2):169-176. doi: 10.1007/s41030-020-00118-5. Epub 2020 May 13.
5
Thoughts on COVID-19 and autoimmune diseases.关于 COVID-19 和自身免疫性疾病的思考。
Lupus Sci Med. 2020 Apr 3;7(1):e000396. doi: 10.1136/lupus-2020-000396. eCollection 2020.
6
Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.分析妊娠期对 COVID-19 的易感性及潜在药物筛选的建议。
Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1209-1220. doi: 10.1007/s10096-020-03897-6. Epub 2020 Apr 23.
7
COVID-19 pathophysiology: A review.新型冠状病毒肺炎的病理生理学:综述。
Clin Immunol. 2020 Jun;215:108427. doi: 10.1016/j.clim.2020.108427. Epub 2020 Apr 20.
8
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.作为针对冠状病毒传染病(COVID-19)的异源人类疫苗,开发 SARS-CoV 受体结合域(RBD)重组蛋白的潜力。
Hum Vaccin Immunother. 2020 Jun 2;16(6):1239-1242. doi: 10.1080/21645515.2020.1740560. Epub 2020 Apr 16.
9
Genotype and phenotype of COVID-19: Their roles in pathogenesis.新型冠状病毒肺炎的基因型和表型:在发病机制中的作用。
J Microbiol Immunol Infect. 2021 Apr;54(2):159-163. doi: 10.1016/j.jmii.2020.03.022. Epub 2020 Mar 31.
10
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.鉴定 2019 新型冠状病毒的受体结合域(RBD):作为病毒附着抑制剂和疫苗开发 RBD 蛋白的意义。
Cell Mol Immunol. 2020 Jun;17(6):613-620. doi: 10.1038/s41423-020-0400-4. Epub 2020 Mar 19.